Rio Tinto Posts Strong Q4 Iron Ore and Copper Output on Operational Recovery 
Elon Musk Seeks $134 Billion in Lawsuit Against OpenAI and Microsoft Over Alleged Wrongful Gains 
Pop Mart Shares Surge in Hong Kong After First Buyback in Nearly Two Years 
White House Pressures PJM to Act as Data Center Energy Demand Threatens Grid Reliability 
Netflix Stock Slips After Earnings as Soft 2026 Guidance Overshadows Subscriber Milestone 
Valentino Garavani Dies at 93, Leaving Behind the Timeless Legacy of Valentino Red 
Nvidia CEO Jensen Huang Plans China Visit Amid AI Chip Market Uncertainty 
Trump Criticizes NYSE Texas Expansion, Calls Dallas Exchange a Blow to New York 
Brazil Supreme Court Orders Asset Freeze of Nelson Tanure Amid Banco Master Investigation 
China Halts Shipments of Nvidia H200 AI Chips, Forcing Suppliers to Pause Production 
Baidu Shares Rise in Hong Kong After Apollo Go Robotaxi Launch in Abu Dhabi 
Renault Group Global Sales Rise 3.2% in 2025 on Strong International and EV Demand 
Global DRAM Chip Shortage Puts Automakers Under New Cost and Supply Pressure 
Syrah Resources and Tesla Extend Deadline on Graphite Supply Dispute to March 
Lynas Rare Earths Shares Surge as Quarterly Revenue Jumps on Strong Prices 
NEW YORK, April 26, 2017 -- The following statement is being issued by Levi & Korsinsky, LLP:
To: All persons or entities who purchased or otherwise acquired shares of INSYS Therapeutics, Inc. (“INSYS”) (NASDAQ:INSY) between February 23, 2016 and March 15, 2017. You are hereby notified that Levi & Korsinsky has commenced the class action Erdmann v. INSYS Therapeutics, Inc.., et al. (Case No. 1:17-cv-02225) in the USDC for the Southern District of New York. Click here to view the complaint. To get more information go to:
http://www.zlk.com/pslra/insys-therapeutics-inc?wire=3
or contact Joseph E. Levi, Esq. either via email at [email protected] or by telephone at (212) 363-7500, toll-free: (877) 363-5972. There is no cost or obligation to you.
The complaint alleges that throughout the Class Period Defendants made false and/or misleading statements and/or failed to disclose that: (1) INSYS had overstated its 2015 net revenue; (2) INSYS had misstated its sales allowances for 2016; (3) accordingly, the Company lacked effective internal controls over financial reporting; and (4) as a result, INSYS public statements were materially false and misleading at all relevant times.
Take Action: if you suffered a loss in INSYS you have until May 16, 2017 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.
Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation, and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT: Levi & Korsinsky, LLP Joseph E. Levi, Esq. 30 Broad Street - 24th Floor New York, NY 10004 Tel: (212) 363-7500 Toll Free: (877) 363-5972 Fax: (212) 363-7171 www.zlk.com
